PL2150253T3 - Zastosowanie 4-cyklopropylometoksy-N-(3,5-dichloro-1-oksydo-pirydyn-4-ylo)-5-(metoksy)pirydyno-2-karboksamidu do leczenia urazów rdzenia kręgowego - Google Patents

Zastosowanie 4-cyklopropylometoksy-N-(3,5-dichloro-1-oksydo-pirydyn-4-ylo)-5-(metoksy)pirydyno-2-karboksamidu do leczenia urazów rdzenia kręgowego

Info

Publication number
PL2150253T3
PL2150253T3 PL08787962T PL08787962T PL2150253T3 PL 2150253 T3 PL2150253 T3 PL 2150253T3 PL 08787962 T PL08787962 T PL 08787962T PL 08787962 T PL08787962 T PL 08787962T PL 2150253 T3 PL2150253 T3 PL 2150253T3
Authority
PL
Poland
Prior art keywords
oxydopyridin
cyclopropylmethoxy
carboxamide
dichloro
pyridine
Prior art date
Application number
PL08787962T
Other languages
English (en)
Inventor
Philippe Delay-Goyet
Badia Ferzaz
Jocelyne Lolivier
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of PL2150253T3 publication Critical patent/PL2150253T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
PL08787962T 2007-04-19 2008-04-16 Zastosowanie 4-cyklopropylometoksy-N-(3,5-dichloro-1-oksydo-pirydyn-4-ylo)-5-(metoksy)pirydyno-2-karboksamidu do leczenia urazów rdzenia kręgowego PL2150253T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0702851A FR2915098B1 (fr) 2007-04-19 2007-04-19 Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des traumatismes de la moelle epiniere
EP08787962A EP2150253B1 (fr) 2007-04-19 2008-04-16 Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1 -oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des traumatismes de la moelle epiniere
PCT/FR2008/000533 WO2008145840A2 (fr) 2007-04-19 2008-04-16 Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1 -oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des traumatismes de la moelle epiniere

Publications (1)

Publication Number Publication Date
PL2150253T3 true PL2150253T3 (pl) 2011-08-31

Family

ID=38779706

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08787962T PL2150253T3 (pl) 2007-04-19 2008-04-16 Zastosowanie 4-cyklopropylometoksy-N-(3,5-dichloro-1-oksydo-pirydyn-4-ylo)-5-(metoksy)pirydyno-2-karboksamidu do leczenia urazów rdzenia kręgowego

Country Status (33)

Country Link
US (1) US8592443B2 (pl)
EP (1) EP2150253B1 (pl)
JP (1) JP5386477B2 (pl)
KR (1) KR101470043B1 (pl)
CN (1) CN101674829B (pl)
AR (1) AR066106A1 (pl)
AT (1) ATE503481T1 (pl)
AU (1) AU2008257321B2 (pl)
BR (1) BRPI0810446A2 (pl)
CA (1) CA2684172C (pl)
CL (1) CL2008001134A1 (pl)
CY (1) CY1111779T1 (pl)
DE (1) DE602008005873D1 (pl)
DK (1) DK2150253T3 (pl)
EA (1) EA015355B1 (pl)
ES (1) ES2363056T3 (pl)
FR (1) FR2915098B1 (pl)
HR (1) HRP20110459T1 (pl)
IL (1) IL201451A (pl)
JO (1) JO2662B1 (pl)
MA (1) MA31369B1 (pl)
ME (1) ME00934B (pl)
MX (1) MX2009011285A (pl)
MY (1) MY146657A (pl)
NZ (1) NZ580483A (pl)
PA (1) PA8776601A1 (pl)
PL (1) PL2150253T3 (pl)
PT (1) PT2150253E (pl)
PY (1) PY08013253A (pl)
SI (1) SI2150253T1 (pl)
TW (1) TWI411435B (pl)
UY (1) UY31033A1 (pl)
WO (1) WO2008145840A2 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2915099B1 (fr) 2007-04-19 2009-06-05 Sanofi Aventis Sa Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des traumatismes craniens
CA2892151A1 (en) * 2012-11-28 2014-06-05 Sanofi Process for preparing 4-(cyclopropylmethoxy)-n-(3,5-dichloro-1-oxido-4-pyridyl)-5-methoxypyridine-2-carboxamide
EP2935219A1 (en) * 2012-11-28 2015-10-28 Sanofi METHOD OF PREPARATION OF CRYSTAL FORMS OF 4-(CYCLOPROPYLMETHOXY)-N-(3,5-DICHLORO-1-OXIDOPYRIDYN-4-yl)-5-METHOXYPYRIDINE-2-CARBOXAMIDE AND CRISTAL FORMS THEREOF
JP2024503727A (ja) 2021-01-20 2024-01-26 アルト ニューロサイエンス，インコーポレーテッド うつ病及び関連する状態の治療のための併用薬物戦略としてのｃＡＭＰシグナル伝達の強化
WO2025079694A1 (ja) * 2023-10-12 2025-04-17 株式会社 メドレックス 経皮吸収組成物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4193926A (en) 1974-03-20 1980-03-18 Schering Aktiengesellschaft 4-(Polyalkoxy phenyl)-2-pyrrolidones
WO1995004045A1 (en) * 1993-07-28 1995-02-09 Rhone-Poulenc Rorer Limited Compounds as pde iv and tnf inhibitors
GB9401460D0 (en) 1994-01-26 1994-03-23 Rhone Poulenc Rorer Ltd Compositions of matter
GB9507297D0 (en) 1995-04-07 1995-05-31 Rh Ne Poulenc Rorer Limited New composition of matter
US6196968B1 (en) 1997-06-02 2001-03-06 General Surgical Innovations, Inc. Direct vision subcutaneous tissue retractor and method for use
US6177077B1 (en) * 1999-02-24 2001-01-23 Edward L. Tobinick TNT inhibitors for the treatment of neurological disorders
PT1244649E (pt) * 1999-12-23 2005-06-30 Icos Corp Inibidores de fosfodiesterase especificos de mfa ciclica
WO2002069905A2 (en) 2001-03-02 2002-09-12 Bristol-Myers Squibb Company Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-amp associated disorders
WO2004005258A1 (en) 2002-07-02 2004-01-15 Merck Frosst Canada & Co. Di-aryl-substituted-ethane pyridone pde4 inhibitors
US20060083714A1 (en) 2003-01-27 2006-04-20 Warner James M Combination of a pde iv inhibitor and a tnf-alpha antagonist
JP2007525482A (ja) * 2003-10-07 2007-09-06 レノビス， インコーポレイテッド イオンチャネルリガンドとしてのアミド化合物およびその使用
WO2006135828A2 (en) * 2005-06-10 2006-12-21 Memory Pharmaceuticals Corporation Trisubstituted amines as phosphodiesterase 4 inhibitors
US20070021451A1 (en) * 2005-07-20 2007-01-25 Hamamatsu University School Of Medicine Method for preventing or treating neurologic damage after spinal cord injury

Also Published As

Publication number Publication date
AR066106A1 (es) 2009-07-22
US8592443B2 (en) 2013-11-26
AU2008257321A1 (en) 2008-12-04
BRPI0810446A2 (pt) 2014-10-14
FR2915098B1 (fr) 2009-06-05
CN101674829B (zh) 2012-01-18
CN101674829A (zh) 2010-03-17
ME00934B (me) 2012-06-20
KR20090130063A (ko) 2009-12-17
JP2010524905A (ja) 2010-07-22
PY08013253A (es) 2013-08-01
ATE503481T1 (de) 2011-04-15
SI2150253T1 (sl) 2011-07-29
PT2150253E (pt) 2011-06-17
US20100137370A1 (en) 2010-06-03
JP5386477B2 (ja) 2014-01-15
HK1142000A1 (en) 2010-11-26
UY31033A1 (es) 2008-11-28
HRP20110459T1 (hr) 2011-07-31
EP2150253B1 (fr) 2011-03-30
CY1111779T1 (el) 2015-10-07
CA2684172C (fr) 2015-10-27
CA2684172A1 (fr) 2008-12-04
KR101470043B1 (ko) 2014-12-05
DK2150253T3 (da) 2011-07-25
FR2915098A1 (fr) 2008-10-24
WO2008145840A2 (fr) 2008-12-04
MX2009011285A (es) 2009-11-02
MY146657A (en) 2012-09-14
AU2008257321B2 (en) 2013-08-15
NZ580483A (en) 2011-06-30
EA015355B1 (ru) 2011-06-30
EP2150253A2 (fr) 2010-02-10
PA8776601A1 (es) 2008-11-19
JO2662B1 (en) 2012-06-17
IL201451A (en) 2013-04-30
ES2363056T3 (es) 2011-07-19
WO2008145840A3 (fr) 2009-06-25
EA200970969A1 (ru) 2010-02-26
DE602008005873D1 (de) 2011-05-12
CL2008001134A1 (es) 2009-01-16
IL201451A0 (en) 2010-05-31
MA31369B1 (fr) 2010-05-03
TW200911248A (en) 2009-03-16
TWI411435B (zh) 2013-10-11

Similar Documents

Publication Publication Date Title
EP1854415A4 (en) SURGICAL TREATMENT DEVICE
EP2124777A4 (en) DEVICES FOR SPINE COLUMN TREATMENT
HUE059861T2 (hu) N-Szubsztituált 2,5-dioxo-azolin vegyületek a rák kezelésében való felhasználásra
IL184710A0 (en) 1-h-pyrrole-2-carboxamides and imidazole-5-carboxamides and use thereof as fak, kdr and tie2 kinase modulators for the treatment of cancer
EP2116255A4 (en) MEANS FOR THE TREATMENT OF BACKBREAK INJURIES
ITMI20072397A1 (it) Apparecchiatura medicale per il trattamento extracorporeo
PL2150253T3 (pl) Zastosowanie 4-cyklopropylometoksy-N-(3,5-dichloro-1-oksydo-pirydyn-4-ylo)-5-(metoksy)pirydyno-2-karboksamidu do leczenia urazów rdzenia kręgowego
ZA201005282B (en) Substituted oxindole-derivatives and the use thereof for the treatment of vasopressin-dependent illnesses
ZA201005306B (en) 5-o-substituted 3-n-phenyl-1,3,4-oxadiazolones for medical use
PT2146714E (pt) Utilização de 4-ciclopropilmetoxi-n-(3,5-dicloro-1-oxidopiridin- 4-il)-5-(metoxi)piridina-2-carboxamida para o tratamento dos distúrbios motores relacionados com a doença de parkinson
PL2146713T3 (pl) Zastosowanie 4-cyklopropylometoksy-N-(3,5-dichloro-1-oksydo-pirydyn-4-ylo)-5-(metoksy)pirydyno-2-karboksyamidu do leczenia urazów mózgowych
GB0710277D0 (en) Use of antivirals in the treatment of medical disorders
GB0721616D0 (en) Treatment of spinal cord injury
TH0801001896A (th) การใช้ 4-ไซโคลโพรพิลเมธอกซิ-n-(3,5-ไดคลอโร-1-ออกซิโด-ไพริดิน-4-อิล)-5-(เมธอกซิ)ไพริดีน-2-คาร์บอกซามีด ในการรักษาการบาดเจ็บไขสันหลัง
GB2438824B (en) Cleaner for medical or veterinary devices, for example auriscopes
GB0401175D0 (en) Infant garment for use with medical devices
ES1067907Y (es) Aparato gimnastico de abdominales extensible apto para usar en la cama o cualquier otra superficie.
GB0704664D0 (en) Treatment device 3
SE0400576D0 (sv) A novel pharmacentical composition for the treatment of spinal cord injury
IL194467A0 (en) Infant treatment apparatus
GB0722338D0 (en) Novel use and treatment